Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sodium/Glucose Cotransporter Inhibitor 2”

40 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 40 results

Testing effectiveness (Phase 2)UnknownNCT04419337
What this trial is testing

Pioglitazone and SGLT2 Inhibitors vs. DPP4 Inhibitors in Patients With Stroke

Who this might be right for
Diabetes MellitusStroke
Chang Gung Memorial Hospital 200
Not applicableStudy completedNCT07269197
What this trial is testing

Association of SGLT2 Inhibitors Therapy With Elastographic and Molecular Markers of Liver Injury in Type 2 Diabetes

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseDiabetes Mellitus, Type 2
Josip Juraj Strossmayer University of Osijek 67
Post-approval studies (Phase 4)Study completedNCT06825156
What this trial is testing

Metabolic and Renal Outcomes in Cardiac Surgery Patients Receiving SGLT2 Inhibitors

Who this might be right for
Acute Kidney Injury
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 60
Not applicableActive Not RecruitingNCT07198191
What this trial is testing

SGLT2 Inhibitor Use After Acute Myocardial Infarction in Patients With Type 2 Diabetes: A Nationwide Cohort Study

Who this might be right for
Acute Myocardial Infarction (AMI)Type 2 Diabetes Mellitus (T2DM)
Yonsei University 200,000
Very early researchLooking for participantsNCT06430684
What this trial is testing

Feasibility Trial of Sodium-GLucose coTransporter 2 INhibitors in Pediatric Chronic KIDney DiSease

Who this might be right for
Chronic Kidney DiseasesPediatric Kidney Disease
Ann & Robert H Lurie Children's Hospital of Chicago 40
Not applicableStudy completedNCT02500186
What this trial is testing

The Clinical Study to Assess the Effect of the Amount of Carbohydrate Intake and Meals Differing in Glycemic Index (GI) in Patients Treated With a Sodium-dependent Glucose Cotransporter 2 (SGLT2) Inhibitor

Who this might be right for
Diabetes Melltius, Type 2
Kansai Electric Power Hospital 24
Large-scale testing (Phase 3)WithdrawnNCT06560333
What this trial is testing

ISGLT2 Inhibitor and a iDPP -4 Inhibitor in Treatment of Type 2 Diabetes Mellitus in Patients Treated With Metformin (TRIAD)

Who this might be right for
Diabetes Mellitus, Type 2
Eurofarma Laboratorios S.A.
Post-approval studies (Phase 4)Study completedNCT02360774
What this trial is testing

Mechanisms of Weight Loss With SGLT2 Inhibition

Who this might be right for
Type 2 DiabetesOverweightObesity
Beth Israel Deaconess Medical Center 30
Large-scale testing (Phase 3)Looking for participantsNCT07653477
What this trial is testing

Phase III Study of UBT251 Injection in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Metformin ± Sulfonylurea/SGLT2 Inhibitor Therapy (UNIGUIDE-2)

Who this might be right for
Type 2 Diabetes
The United Bio-Technology (Hengqin) Co., Ltd. 956
Testing effectiveness (Phase 2)Study completedNCT03316131
What this trial is testing

Assess the Effect of Intensive Uric Acid (UA) Lowering Therapy With RDEA3170, Febuxostat, Dapagliflozin on Urinary Excretion of UA

Who this might be right for
Asymptomatic Hyperuricemia
AstraZeneca 36
Testing effectiveness (Phase 2)Study completedNCT05232071
What this trial is testing

Placebo-controlled, Proof-of-concept Study to Evaluate the Safety and Efficacy of Lanifibranor Alone and in Combination With SGLT2 Inhibitor EmpaGliflozin in patiEnts With NASH and Type 2 Diabetes Mellitus

Who this might be right for
NASH - Nonalcoholic SteatohepatitisDiabetes Mellitus, Type 2
Inventiva Pharma 39
Testing effectiveness (Phase 2)Looking for participantsNCT06528405
What this trial is testing

The Efficacy and Safety of Sodium-glucose Cotransporter 2 Inhibitors in Patients With Acute Kidney Disease

Who this might be right for
Acute Kidney Injury
National Taiwan University Hospital 264
Post-approval studies (Phase 4)Looking for participantsNCT06668389
What this trial is testing

Sodium-Glucose Cotransporter 2 Inhibitors for Repaired Tetralogy of Fallot Patients for Enhancement of Cardio-Pulmonary Status Trial

Who this might be right for
Congenital Heart DiseaseRepaired Tetralogy of Fallot (rTOF)Pulmonary Regurgitation+2 more
The University of Hong Kong 106
Post-approval studies (Phase 4)Looking for participantsNCT07240844
What this trial is testing

Enavogliflozin for the Management of Patients With Amyloid CardiomyopaThy

Who this might be right for
Amyloid Cardiomyopathy
Seoul St. Mary's Hospital 68
Post-approval studies (Phase 4)Looking for participantsNCT07482943
What this trial is testing

The Effect of Dapagliflozin on Exercise and Cardiac Functional Status of Patients After Fontan Procedure

Who this might be right for
FontanHeart FailureDapagliflozin+2 more
The University of Hong Kong 30
Early research (Phase 1)Study completedNCT06828731
What this trial is testing

Evaluation of Empagliflozin vs Standard Care in Veterans With Prediabetes

Who this might be right for
Prediabetes
Charles George VA Medical Center 60
Large-scale testing (Phase 3)Ended earlyNCT03933956
What this trial is testing

Metabolic Effects of the SGLT-2 Inhibitor Empagliflozin in Patients With Diabetic Nephropathy (MEDiaN)

Who this might be right for
Diabetic Nephropathies
Singapore General Hospital 2
Post-approval studies (Phase 4)UnknownNCT05975528
What this trial is testing

Effect of Sodium-glucose Cotransporter-2 Inhibitor in Cellular Senescence in Patients With Cardiovascular Diseases or Type 2 Diabetes

Who this might be right for
Diabetes MellitusCellular SenescenceSodium-Glucose Transporter 2 Inhibitors
Yonsei University 92
Post-approval studies (Phase 4)Active Not RecruitingNCT06933355
What this trial is testing

Acute Effects of SGLT2 Inhibitor on Kidney Allograft Oxygen Tension

Who this might be right for
Kidney Transplantation RecipientsMagnetic Resonance Imaging (MRI)Sodium-Glucose Transporter 2 Inhibitors+3 more
Odense University Hospital 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT05687058
What this trial is testing

Empagliflozin in ESKD - A Feasibility Study

Who this might be right for
Kidney Failure, ChronicHeart Failure
University of Mississippi Medical Center 24
Next Page